Max Robotics — Global Service Robot Directory + US Certification

About

Lu Zang is a leading surgical oncologist whose research has fundamentally shaped the modern approach to gastric cancer treatment. Her work centers on the comparative effectiveness of minimally invasive techniques—specifically robotic, laparoscopic, and open gastrectomy—with the goal of defining the safest and most effective surgical pathway for patients. Zang’s landmark 2017 propensity score-matched study, which has garnered over 100 citations, provided critical evidence that robotic and laparoscopic approaches can achieve oncological outcomes comparable to open surgery while offering superior recovery benefits. She has been instrumental in establishing the International Study Group on Minimally Invasive Surgery for GASTRIc Cancer (IMIGASTRIC), designing multi-institutional protocols that set the standard for evidence-based surgical research. Through her comprehensive literature reviews and prospective study designs, Zang has systematically addressed the limitations of existing evidence, pushing the field toward greater adoption of minimally invasive methods. Her work is essential reading for any surgeon or researcher seeking to understand the evolving landscape of gastric cancer surgery and the rigorous comparative data needed to guide clinical decision-making.